Effect of 24 months of recombinant growth hormone on height and body proportions in SHOX haploinsufficiency.

Munns, C F J; Berry, M; Vickers, D; Rappold, G A; Hyland, V J; Glass, I A; Batch, J A

Munns, C F J; Berry, M; Vickers, D; Rappold, G A; Hyland, V J; Glass, I A; Batch, J A.

Affiliation

Munns CF; Endocrine and Diabetes Research Unit, Royal Children's Hospital Foundation Research Centre, Brisbane, Australia. cmunns@shriners.mcgill.ca

J Pediatr Endocrinol Metab ; 16(7): 997-1004, 2003 Sep.

Article in En | MEDLINE | ID: mdl-14513876

Subject(s)

Body Height/drug effects; Body Height/genetics; Growth Disorders/drug therapy; Growth Disorders/genetics; Growth Hormone/therapeutic use; Homeodomain Proteins/genetics; Adolescent; Arm/anatomy & histology; Arm/growth & development; Bone and Bones/diagnostic imaging; Child; Female; Hand/diagnostic imaging; Haplotypes; Humans; In Situ Hybridization, Fluorescence; Karyotyping; Leg/anatomy & histology; Leg/growth & development; Male; Phenotype; Radiography; Short Stature Homeobox Protein

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Body Height / Growth Hormone / Homeodomain Proteins / Growth Disorders Type of study: Diagnostic_studies Limits: Adolescent / Child / Female / Humans / Male Language: En Journal: J Pediatr Endocrinol Metab Journal subject: ENDOCRINOLOGIA / PEDIATRIA Year: 2003 Type: Article Affiliation country: Australia

Search on Google

XML

PubMed Links